Victor A. Folgosi
Sao Paulo, SP, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Asymptomatic is not silent: proposal of HTLV-1-associated multiple inflammatory disease as an early neuroinflammatory state.
Journal: Expert review of anti-infective therapy
Published: June 25, 2026
Spontaneous lymphoproliferation differentiates two groups of HTLV-1 asymptomatic carriers: with and without high cell proliferation and death.
Journal: Immunologic research
Published: May 05, 2026
HTLV-1-associated diseases: a systematic review.
Journal: Revista do Instituto de Medicina Tropical de Sao Paulo
Published: March 19, 2026
HIV expression persists in the cerebrospinal fluid of HIV-associated neurocognitive disorders despite effective ART.
Journal: Emerging microbes & infections
Published: January 13, 2026
Cytometric Analysis of CD3 + CD4 + T Populations and Activation and Regulation Status of Naïve and Memory CD4 + CD45RA T Cells in Immunocompetent Patients with Neurocryptococcosis.
Journal: Mycopathologia
Published: June 20, 2025
Seroprevalence of HTLV-½ in Macapá-AP, Brazil, in general population.
Journal: Revista da Sociedade Brasileira de Medicina Tropical
Published: June 10, 2025
Multi-cohort cross-omics analysis reveals disease mechanisms and therapeutic targets in HTLV-1-associated myelopathy, a neglected retroviral neuroinflammatory disorder.
Journal: Research square
Published: May 09, 2025
Investigating STLV-1 infection in African green monkeys: a model for understanding HTLV-1 pathogenesis.
Journal: Frontiers in medicine
Published: April 22, 2025
Persistent Human T-Lymphotropic Virus Type 1 (HTLV-1) Infection in the Placenta of Pregnant Women.
Journal: Journal of medical virology
Published: February 06, 2025
HTLV-1 and HTLV-2 infections significantly alter small RNA expression in asymptomatic carriers.
Journal: Frontiers in medicine
Published: December 18, 2024
Eradicating latent tuberculosis: use of interferon gamma release assay and isoniazid/rifapentine in people living with HIV/AIDS.
Journal: Revista do Instituto de Medicina Tropical de Sao Paulo
Published: November 20, 2024
Last Updated: 09/26/2026